-
Innovation Remains Key Aid To MR's Expansion
Wednesday, March 2, 2011 - 9:01am | 111While it may take another quarter or two for Mindray Medical International (NYSE: MR) to demonstrate that its double-digit China non-tender sales growth is sustainable and the 10%+ 2011 net income growth guidance is deliverable, “we think the story could experience accelerated bottom-line growth in...
-
Cyberonics Reports Q3 EPS of $0.25
Wednesday, March 2, 2011 - 8:56am | 54Cyberonics (NASDAQ: CYBX) reported its Q3 EPS at $0.25, versus the consensus of $0.24. CYBX reported its Q3 revenue at $47.1 million, versus the consensus of $46.45 million. CYBX shares fell 1.60% to close at $32.50 yesterday. Read more from Benzinga's Company news.
-
Piper Jaffray Reiterates OW Rating, $26 PT On MAKO
Wednesday, March 2, 2011 - 8:23am | 162MAKO Surgical Corp.'s (NASDAQ: MAKO) solid outlook frames out expectations for another year of robust of growth, while also leaving room for upside, potentially driven by the hip system or outperformance in terms of robot placements or utilization, Piper Jaffray reports. “In terms of revenues for...
-
Options Brief: Covidien Public Limited Company (COV)
Tuesday, March 1, 2011 - 11:50am | 92Shares of Covidien Public Limited Company (NYSE: COV) are lower on the session by 0.06%, trading at $51.42. Overall call volume is now running at 3.15x the daily average, with 3% of all calls traded being purchases on the offer. 9,706 contracts have traded on the session so far. Covidien Public...
-
Oppenheimer Comments On Mindray Medical Ltd. Following Recent Earnings Report
Tuesday, March 1, 2011 - 8:29am | 157Mindray Medical's (NYSE: MR) 4Q results were largely in line with its preliminary announcement in January. The first-time 2011 net income guidance of north of 10% may disappoint some, but reasonable given the investment in SG&A and R&D and was in line with Oppenheimer's forecast. Separately...
-
Benchmark Reports Q4 EPS And 2011 Guidance Well Below Consensus for IRIS International
Tuesday, March 1, 2011 - 8:20am | 151According to Benchmark, IRIS International (NASDAQ: IRIS) had Q4 EPS and 2011 Guidance well below consensus. Benchmark reported that revenue of $29.3 million in 4Q10 slightly exceeded the consensus $28.8 million forecast but EPS of $0.03 missed the $0.06 consensus. “Weakness was attributed to...
-
Mindray Medical to Acquire a Controlling Stake in Shenke Medical
Monday, February 28, 2011 - 6:00pm | 49Mindray Medical International Limited (NYSE: MR) announced today an agreement to acquire a controlling stake of Shenzhen Shenke Medical Instrument Technical Development Co. Ltd. The terms of the transaction were not disclosed as the transaction is non-material to Mindray's financial statements.
-
Abiomed, Inc. Director Sells 29,695 Shares of ABMD
Monday, February 28, 2011 - 5:06pm | 54In a Form 4 filed earlier today, Abiomed, Inc. (NASDAQ: ABMD) Director, Henri Termeer, reported that he sold 29,695 shares of ABMD on February 24th – 25th for an average price of $12.52. The transaction totaled $371,755. Mr. Termeer owns 60,100 direct shares and 1,785,601 indirect shares of ABMD....
-
Calls Purchased on China Medical Technologies (CMED)
Monday, February 28, 2011 - 1:52pm | 130Shares of China Medical Technologies (NASDAQ: CMED) are lower on the session by 0.15%, currently trading at $13.17. The stock has been moving largely higher over the past three months and is currently trading above the 50-day and 20-day moving averages. Options traders are buying calls on the name...
-
Medtronic Revives Physio-Control Spinoff
Monday, February 28, 2011 - 1:19pm | 56In an attempt to mimic the company's lifesaving products, Medtronic (MDT) announced that plans to divest its Physio-Control subsidiary have been revived. While overshadowed by broader restructuring plans, the Physio announcement was made during the company's Q3 earnings release and elaborated on (a...
-
Medtronic Mosaic® Heart Valve Demonstrates Long-Term Durability in International Study
Monday, February 28, 2011 - 11:02am | 105Medtronic, Inc. (NYSE: MDT) today announced that its Mosaic® bioprosthetic heart valve has demonstrated positive performance results at 12 years in a study published online in The Journal of Thoracic and Cardiovascular Surgery. The Mosaic valve was evaluated in patients who had aortic valve...
-
Varian Medical Systems Announces $280M Accelerated Stock Repurchase
Monday, February 28, 2011 - 9:07am | 43Varian Medical Systems, Inc. (NYSE: VAR) today announced that it has entered into a new agreement with Bank of America N.A. to repurchase $280 million of its common stock under an accelerated share repurchase program.
-
Piper Jaffray Reiterates OW Rating, $63 PT On BAX
Monday, February 28, 2011 - 9:04am | 134Piper Jaffray is reiterating its Overweight rating and $63 PT on shares of Baxter International Inc. (NYSE: BAX). “Adjusted ‘apples-to-apples' growth of US IVIG distribution accelerated in January, up 25% year-over-year, compared to 15% growth in December,” Piper Jaffray writes. “The robust growth...
-
Oppenheimer Has Perform On Mindray Medical (MR)
Monday, February 28, 2011 - 8:51am | 157Oppenheimer & Co. has a Perform rating on shares of Mindray Medical Int'l Ltd. (NYSE: MR). In a note to clients, Oppenheimer writes, "Recently, NDRC released a list of key software enterprises for 2010 and Mindray was again awarded key software enterprise status for its Shenzhen subsidy. While...
-
Top 4 Stocks In The Research Services Industry With The Highest ROE (GPRO, MYGN, ACTG, FORR)
Monday, February 28, 2011 - 2:36am | 140Below are the top research service stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Acacia Research Corporation (NASDAQ: ACTG) is 49.73%. ACTG's profit margin for the same period is 25.00%. The trailing-twelve-month return on equity at...